DocFlight, Founded by Former FDA Official Sally Wang, Files IPO Prospectus Highlighting AI-Driven Direct Access to U.S. Top Physicians

”There are many companies providing cross-border medical services both domestically and internationally, but most of them act as intermediaries connecting with agencies or the international departments of hospitals. The biggest difference between Meiyue Mingyi (Meiyue Famous Doctors) and them is that we directly connect patients with renowned U.S. physicians and medical services.“In an interview with VCBeat, Wang Yuanheng (Sally), founder of Meiyue Mingyi, explained what sets her company apart in the wave of cross-border healthcare startups.”

Domestic cross-border telemedicine originated in China in 2011. In VCBeat’s annual review this year, it was noted that 49 Chinese companies now offer such services. However, few of them bypass hospital international departments to connect directly with physicians and medical services; Mei Yue Ming Yi is one such exception, which VCBeat has tracked and reported on.

When discussing the original motivation for starting her business, founder Sally stated that it was closely tied to her personal experiences. Sally studied biology as an undergraduate at Harvard University. Despite what had been a smooth and successful academic journey, she developed life-threatening generalized myasthenia gravis after graduation, prompting her, at a young age, to embark on a long and arduous quest for medical treatment and remedies.

Sally sought out Dr. Anthony Amato, a leading authority in her disease field and a neuroscience specialist at Harvard’s Brigham and Women’s Hospital. Dr. Amato’s meticulous care not only helped restore her physical health but also provided immense psychological support. While actively cooperating with Dr. Amato’s treatment plan, she has remained dedicated to her work in healthcare consulting.

She observed that, due to information asymmetry, many patients took detours in the early stages of seeking medical care. Drawn by the reputation of large hospitals, they failed to find genuine specialists, resulting in consistently unsatisfactory treatment outcomes. This not only took a toll on their physical health but also imposed significant psychological stress, gradually diminishing their hopes for recovery.

Driven by the empathy born from her own illness, Sally devoted herself to understanding the U.S. pharmaceutical market and amassed extensive industry insights. After successfully completing her treatment, she was admitted to Harvard Law School, where she earned a joint Juris Doctor (J.D.) and Master of Public Health (MPH).

In 2014, Sally’s mother was diagnosed with breast cancer. Leveraging her extensive background in the pharmaceutical industry once again, Sally secured the expertise of Dr. Eric Winer, a renowned authority at the Dana-Farber Cancer Institute of Harvard Medical School, helping her mother regain her health.

These experiences have given Sally a profound understanding of how critical excellent physicians and professional, responsible care are to patients. Inspired by this realization, she resolutely gave up a million-dollar annual salary after graduating from Harvard Law School and decided to found DocFlight, aiming to bring the most advanced and premier medical resources from the United States to patients in China.

Ultimately, launching a startup is not something that can be accomplished on a mere whim or simply by having an idea. After resolving to start her own business, Sally began seeking out talented individuals from various fields. While the genesis of entrepreneurship may stem from ideals, its execution demands reliability and professionalism. Therefore, although the Meiyue Mingyi team is not yet large in scale, each member is a seasoned practitioner within the industry. For instance, the company’s CTO, Liu Zongyuan, is a former Senior Engineer at Goldman Sachs and holds a master’s degree from Carnegie Mellon University.。

Other team members also boast credentials from prestigious U.S. universities such as Carnegie Mellon University and the University of North Carolina, along with years of professional experience at top-tier hospitals and institutions including Peking University Third Hospital and the World Health Organization. In short, although the team is young, each member is a seasoned veteran in the industry.

Meanwhile, as a telemedicine platform, Mei Yue Ming Yi’s core service offering is its elite medical team behind the scenes. Carefully selected by Mei Yue Ming Yi, these physicians hail from NYU Langone Health, Harvard-affiliated hospitals, Harvard Medical School, Brigham and Women’s Hospital, and the Dana-Farber Cancer Institute, and they all enjoy high prestige and reputation within the industry.

Meiyue Mingyi is fully confident in its selection of top-tier physicians. Drawing from her own experiences seeking medical care, Sally has come to realize that even doctors at prestigious hospitals are not necessarily experts or leaders in their specific fields. To identify physicians who can truly provide effective and actionable advice for patients, one must have substantial professional networks and in-depth knowledge of the U.S. healthcare industry.

Leveraging their extensive experience, robust network of physicians, and the application of big data, Sally and her team have effortlessly overcome this challenge. The true value of Meiyue’s renowned physicians lies in their mastery of the latest treatment techniques and their wealth of clinical experience.

The figure above illustrates the comprehensive medical consultation process offered by Meiyue Mingyi.

As Sally stated in an interview, there are currently numerous companies operating in the cross-border healthcare sector both domestically and internationally. What enables Meiyue Mingyi to stand out from the competition? Seizing this opportunity, Sally presented the company’s “exclusive advantages” to VCBeat—

Rooted in the U.S., with Top-Tier Medical Resources:Meiyue Mingyi is an overseas medical services company headquartered in New York. Leveraging its strategic geographic location, the company integrates advanced medical resources in the Northeastern United States and has established collaborations with renowned specialists at leading hospitals in Boston, New York, Philadelphia, and other cities. It pioneered the “Direct Access to Renowned Specialists” model, facilitating direct engagement with top-tier physicians to ensure the highest quality of medical expertise.

Elite Team:Sally holds three degrees: a Bachelor’s in Biology from Harvard University, a Juris Doctor from Law School, and a Master’s in Public Health.and has previously served at the U.S. Food and Drug Administration (FDA) and the U.S. Senate, while providing strategic consulting services to renowned Fortune 500 pharmaceutical companies。

Other core team members also hold master’s or higher degrees from top U.S. universities. With diverse backgrounds, they all possess extensive work experience at world-renowned medical companies or institutions. This professional team provides a solid guarantee for customer service.

Big Data Online Automation Platform:The DocFlight online automation platform, uniquely developed by the CTO who formerly served as a Senior Engineer at Goldman Sachs, leverages big data analytics and machine learning to maximize the replacement of manual processes. This significantly enhances the service capabilities of Meiyue Mingyi (Meiyue Renowned Doctors), reduces service costs, and ensures service quality.

As a U.S.-based company, MeiYue Mingyi boasts unique advantages. Since its establishment in 2016, it has steadily expanded its presence in China, partnering with institutions such as Renhe Pharmaceutical, Shanghai Skin Disease Hospital, Hainan Haiyao, Microsoft, and other medical organizations, multinational corporations, and health groups.

Over the next three years, MeiYue MingYi will focus on expanding its China-U.S. telemedicine market, establishing robust and stable patient acquisition channels, and enhancing core technological barriers and service processes, ultimately becoming a medical resource hub within the China-U.S. cross-border healthcare ecosystem.

Meanwhile, as a U.S.-based international healthcare technology company, Meiyue Mingyi possesses unparalleled advantages in global expansion compared to Chinese companies. The company plans to gradually expand into the Americas, Europe, and Southeast Asia over the next 5 to 10 years, building on its established presence in the Chinese market.